Skip to main content
Equibles

HighTower Advisors, LLC

Position in CSBR — Champions Oncology, Inc.

CIK 1462245 CHICAGO, IL
Back to CSBR Full portfolio

Position in CSBR

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$258,110
+$55,952 QoQ
Shares Held
41,901
+19.2% QoQ
Ownership
0.301%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 28 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CSBR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. CSBR ranks #59 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 870,551 $82,484,707
2 REGN
Regeneron Pharmaceuticals, Inc.
 64,650 $40,311,861
3 ALNY
Alnylam Pharmaceuticals, Inc.
 105,045 $31,621,696
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 49,020 $24,349,704
5 RPRX
Royalty Pharma plc
 285,630 $16,015,274
6 EXEL
Exelixis, Inc.
 291,162 $15,842,124
7 AXSM
Axsome Therapeutics, Inc.
 56,313 $13,783,733
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 140,394 $11,443,514

All Filings in CSBR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $258,110 41,901
2026-03-31 $202,158 35,158
2025-12-31 $242,941 35,158
2025-09-30 $227,823 35,158
2025-06-30 $259,114 35,158
2025-03-31 $305,171 35,158
2024-12-31 $336,869 39,308
2024-09-30 $191,429 39,308
2024-06-30 $177,372 34,308
2024-03-31 $168,109 34,308
2023-12-31 $175,557 31,238
2023-09-30 $193,987 31,238
2023-06-30 $199,298 31,238
2023-03-31 $125,576 31,238
2022-12-31 $140,883 31,238
2022-09-30 $198,502 26,467
2022-06-30 $211,736 26,467
2022-03-31 $215,176 26,467
2021-12-31 $221,264 26,467
2021-09-30 $270,228 26,467
2021-06-30 $199,709 19,427
2021-03-31 $219,525 19,427
2020-12-31 $179,114 16,600
2020-09-30 $153,550 16,600
2020-06-30 $158,696 16,600
2020-03-31 $122,840 16,600